A recent analysis has examined the state of the vaccine ecosystem in Africa, including research and development funding, clinical trials, regulation, and manufacturing readiness. The analysis suggests that while some aspects of vaccine manufacturing in Africa are strong, such as form/fill/finish capacity, other areas may require additional investment to achieve end-to-end local vaccine production. The overall picture of Africa's vaccine manufacturing capacity is described as mixed, with both investments and gaps identified.